Trials / Unknown
UnknownNCT03875261
Effect of Cannabinoid (THC / CBD 50%) on Hyperalgesia in Patients With Deep Endometriosis
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- David Garcia Cinca · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the treatment of the symptoms of deep endometriosis with a cannabinoid derivate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabinoid treatment | Participants are treated with cannabinoid derivates with a dose between 1 to 12 puffs, each puffs contains 2,7 mg of delta-9-tetrahidrocannabinol and 2,5 mg of cannabidiol. |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2019-07-15
- Completion
- 2019-07-15
- First posted
- 2019-03-14
- Last updated
- 2019-03-14
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03875261. Inclusion in this directory is not an endorsement.